pargyline has been researched along with methyldopa in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 54 (90.00) | 18.7374 |
1990's | 1 (1.67) | 18.2507 |
2000's | 1 (1.67) | 29.6817 |
2010's | 4 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Khattri, HN; Wahi, PL | 1 |
Nies, AS | 1 |
Sjoerdsma, A | 1 |
Mosnaim, AD; Silkaitis, RP | 1 |
Maître, L; Waldmeier, PC | 1 |
Sabelli, HC; Vazquez, AJ | 1 |
Day, MD; Peters, AS | 1 |
Bałuk, P; Gabella, G | 1 |
Kilbinger, H; Racké, K; Schwörer, H | 1 |
Borchardt, RT; Scriba, GK | 1 |
Vidt, DG | 2 |
Selchau, M | 1 |
Stock, K; Westermann, E | 1 |
Norberg, KA | 1 |
Farmer, JB | 1 |
Renyi, AL; Ross, SB | 1 |
Moyer, JH; Onesti, G | 1 |
Palmer, RF | 1 |
Seedat, YK | 1 |
Gilmore, HR | 1 |
Dhasmana, KM; Fokker, WA; Spilker, BA | 1 |
Hamilton, AE; Horita, A; Nair, X | 1 |
Behla, M; Fröhling, P; Lemke, E; Lindenau, K | 1 |
Uretsky, NJ | 1 |
Burke, GE | 1 |
Herting, RL; Hunter, HL | 1 |
Brest, AN; Kim, KE; Onesti, G; Schwartz, AB; Swartz, C | 1 |
Bartholini, G; Kuruma, I; Pletscher, A | 1 |
Giardina, WJ; Sabelli, HC | 1 |
Koe, BK; Weissman, A | 2 |
Clark, MA; Lee, RE; Oates, JA; Rousseau, P; Seligmann, AW | 1 |
Brest, AN; Chinitz, J; Kim, E; Onesti, G; Seller, R; Swartz, C | 1 |
Beroniade, V; Nestor, G; Tutunaru, M | 1 |
Rand, MJ; Trinker, FR | 1 |
Davis, PW; Horita, A | 1 |
Pomerantz, HZ | 1 |
Paykel, ES | 1 |
Smith, CB | 1 |
Onesti, G | 1 |
Abrahim, H; Montoreano, F; Plotquin, J | 1 |
Parkinson, D; Rando, RR | 1 |
BREST, AN; MOYER, JH | 2 |
DALMAU-CIRIA, M | 1 |
DOCTOR, RB; OATES, JA | 1 |
ROWE, WS | 1 |
BREST, AN; HEIDER, C; MOYER, JH; ONESTI, G; SELLER, RH | 1 |
HARRIS, JE | 1 |
BALMER, VG | 1 |
BREST, AN | 1 |
MIZGALA, HF | 1 |
LINDMAR, R; MUSCHOLL, E | 1 |
ABRAMS, WB; BATES, H; CAMACHO, S; HANAUER, L; MOE, RA; POCELINKO, R | 1 |
6 review(s) available for pargyline and methyldopa
Article | Year |
---|---|
Choice of antihypertensive drugs for the treatment of hypertension, including hypertensive emergencies.
Topics: Antihypertensive Agents; Bethanechol Compounds; Clonidine; Diazoxide; Diuretics; Emergencies; Ferricyanides; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Muscle, Smooth; Pargyline; Propranolol; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; Vasodilator Agents | 1974 |
[Angiotics. 48. I. Hypertensive agents. II. Hypotensive agents. 3. Vasodilator agents. IV. Agents for the treatment of lipid metabolism disorders].
Topics: Acetylcholine; Adenosine Triphosphate; Amines; Angiotensin II; Anticholesteremic Agents; Antihypertensive Agents; Diazoxide; Ergot Alkaloids; Humans; Hyperlipidemias; Kallikreins; Lipid Mobilization; Methyldopa; Nicotinic Acids; Parasympatholytics; Pargyline; Phenethylamines; Phytotherapy; Plants, Medicinal; Propylamines; Protoveratrines; Purines; Rauwolfia; Sympatholytics; Sympathomimetics; Tissue Extracts; Vasodilator Agents | 1970 |
The treatment of chronic hypertension.
Topics: Adult; Blood Pressure Determination; Chronic Disease; Diuretics; Female; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; Pargyline; Phytotherapy; Plants, Medicinal; Propranolol; Rauwolfia; Reserpine | 1971 |
The physiologic and pharmacologic basis for the clinical treatment of hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Emergencies; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Pargyline; Pentolinium Tartrate; Reserpine | 1967 |
ANTIHYPERTENSIVE DRUGS AND GENERAL ANAESTHESIA.
Topics: Anesthesia; Anesthesia, General; Antihypertensive Agents; Bretylium Compounds; Carbamates; Diuretics; Drug Therapy; Ganglionic Blockers; Guanethidine; Hydralazine; Methyldopa; Pargyline; Rauwolfia; Veratrum | 1965 |
NEWER DRUGS IN THE TREATMENT OF HYPERTENSION.
Topics: Antihypertensive Agents; Bretylium Compounds; Chlorothiazide; Chlorthalidone; Diuretics; Drug Therapy; Essential Hypertension; Guanethidine; Hydralazine; Hypertension; Methyldopa; Pargyline; Rauwolfia; Spironolactone; Toxicology | 1965 |
2 trial(s) available for pargyline and methyldopa
Article | Year |
---|---|
Hypertension: effectiveness of two drugs.
Topics: Antihypertensive Agents; Benzothiadiazines; Clinical Trials as Topic; Diuretics; Enzyme Therapy; Humans; Hydrochlorothiazide; Hypertension; Methyclothiazide; Methyldopa; Monoamine Oxidase Inhibitors; Pargyline | 1967 |
The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.
Topics: Clinical Trials as Topic; Guanethidine; Humans; Hypertension; Hypotension, Orthostatic; Methyldopa; Pargyline | 1965 |
52 other study(ies) available for pargyline and methyldopa
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Drug treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Debrisoquin; Diazoxide; Diuretics; Female; Humans; Hypertension; Male; Methyldopa; Pargyline; Secologanin Tryptamine Alkaloids | 1976 |
Adverse reactions and interactions limiting the use of antihypertensive drugs.
Topics: Antihypertensive Agents; Blood Pressure; Depression; Dose-Response Relationship, Drug; Drug Interactions; Fever; Ganglionic Blockers; Guanethidine; Humans; Hypertension; Methyldopa; Pargyline; Plasma Volume; Posture; Reserpine; Sympathetic Nervous System | 1975 |
Central action as a key to past and future therapy of hypertension.
Topics: Atropine; Brain; Humans; Hypertension; Methyldopa; Pargyline; Phenobarbital; Propranolol; Receptors, Adrenergic; Research Design | 1977 |
Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brain.
Topics: Animals; Brain; Hydrazines; Male; Methyldopa; Pargyline; Phenethylamines; Phenylalanine; Rabbits; Tyramine | 1976 |
Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cisterna Magna; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Injections; Injections, Intravenous; Levodopa; Methyldopa; Monoamine Oxidase; Pargyline; Rats; Time Factors; Tyrosine | 1976 |
Potentiation of the central nervous system effects of DOPA by decarboxylase inhibition: possible direct role of this neuroamino acid in brain mechanisms.
Topics: Agonistic Behavior; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Brain; Depression, Chemical; Dihydroxyphenylalanine; Disulfides; Dopa Decarboxylase; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Evoked Potentials; Methyldopa; Methyltyrosines; Mice; Motor Activity; Pargyline; Phenethylamines; Piperazines; Rabbits; Reserpine; Somatosensory Cortex; Stimulation, Chemical; Sulfhydryl Compounds; Visual Cortex | 1975 |
Proceedings: Effect of propranolol treatment on the development of DOCA/saline hypertension in rats.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Male; Methyldopa; Pargyline; Propranolol; Rats; Stimulation, Chemical | 1975 |
Some parasympathetic neurons in the guinea-pig heart express aspects of the catecholaminergic phenotype in vivo.
Topics: Animals; Catecholamines; Dopamine; Dopamine beta-Hydroxylase; Female; Ganglia, Autonomic; Guinea Pigs; Heart; Immunohistochemistry; Levodopa; Male; Methyldopa; Neurons; Norepinephrine; Pargyline; Phenotype; Serotonin; Sympathectomy, Chemical; Tyrosine 3-Monooxygenase | 1990 |
Spontaneous release of endogenous 5-hydroxytryptamine and 5-hydroxyindoleacetic acid from the isolated vascularly perfused ileum of the guinea-pig.
Topics: Animals; Calcium; Guinea Pigs; Hydroxyindoleacetic Acid; Ileum; Imipramine; In Vitro Techniques; Male; Methyldopa; Myenteric Plexus; Pargyline; Perfusion; Portal Vein; Serotonin; Tetrodotoxin; Tryptophan | 1987 |
Metabolism of catecholamine esters by cultured bovine brain microvessel endothelial cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cattle; Cells, Cultured; Deoxyepinephrine; Dopamine; Endothelium, Vascular; Isoflurophate; Methyldopa; Microcirculation; Pargyline; Prodrugs; Vasodilator Agents | 1989 |
[On the significance of the noradrenaline content of fatty tissue for the mobilization of unesterified fatty acids].
Topics: Adipose Tissue; Adrenal Medulla; Animals; Cocaine; Cold Temperature; Enzymes; Epididymis; Epinephrine; Fatty Acids; In Vitro Techniques; Lipids; Male; Metaraminol; Methyldopa; Methyltyrosines; Nialamide; Norepinephrine; Normetanephrine; Octopamine; Pargyline; Rats; Reserpine; Transaminases; Tyramine; Tyrosine; Tyrosine Transaminase | 1965 |
Drug-induced changes in monoamine levels in the sympathetic adrenergic ganglion cells and terminals. A histochemical study.
Topics: 5-Hydroxytryptophan; Animals; Catecholamines; Dihydroxyphenylalanine; Dopamine; Ephedrine; Ganglia, Autonomic; Hydrazines; Methyldopa; Microscopy, Fluorescence; Nerve Endings; Neurochemistry; Nialamide; Pargyline; Rats; Reserpine; Tranylcypromine; Tyrosine | 1965 |
Impairment of sympathetic nerve responses by dopa, dopamine and their alpha-methyl analogues.
Topics: Animals; Cats; Dihydroxyphenylalanine; Dopamine; Epinephrine; Methyldopa; Nictitating Membrane; Norepinephrine; Pargyline; Sympathetic Nervous System; Sympathomimetics | 1965 |
In vitro inhibition of noradrenaline-3H uptake by reserpine and tetrabenazine in mouse cerebral cortex tissues.
Topics: Animals; Cerebral Cortex; Chlorpromazine; Diiodotyrosine; Hydrazines; In Vitro Techniques; Methyldopa; Mice; Norepinephrine; Normetanephrine; Pargyline; Reserpine; Tetrabenazine; Tranylcypromine; Tritium | 1966 |
Hypertension past 60.
Topics: Aged; Benzothiadiazines; Chlorthalidone; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Pargyline; Phytotherapy; Plants, Medicinal; Rauwolfia; Reserpine | 1967 |
Antihypertensive agents.
Topics: Antihypertensive Agents; Bretylium Compounds; Diuretics; Ganglionic Blockers; Guanethidine; Hydralazine; Methyldopa; Pargyline; Plants, Medicinal; Plants, Toxic; Reserpine; Veratrum | 1968 |
The medical treatment of hypertension.
Topics: Antihypertensive Agents; Chlorothiazide; Diet Therapy; Emergencies; Furosemide; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Pargyline; Phytotherapy; Plants, Medicinal; Plants, Toxic; Potassium; Propranolol; Reserpine; Veratrum | 1970 |
Peripheral cardiovascular effects, in the pithed rat, of compounds used in the treatment of hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Cordotomy; Diazoxide; Electric Stimulation; Ergotamine; Guanethidine; Hydrochlorothiazide; Iproniazid; Male; Mecamylamine; Methyldopa; Pargyline; Phenobarbital; Rats; Reserpine; Sympathetic Nervous System; Thiocyanates; Trimethaphan | 1972 |
L- -methyl- -hydrazino- -(3,4-dihydroxyphenyl)propionic acid: relative lack of antidecarboxylase activity in adrenals.
Topics: 5-Hydroxytryptophan; Adrenal Glands; Animals; Brain Chemistry; Carboxy-Lyases; Catechols; Female; Hydrazines; Kidney; Methyldopa; Pargyline; Propionates; Rats; Serotonin; Time Factors | 1972 |
[Long-term therapy of renal hypertension with various antihypertensive combinations in nephrologic dispensary consultations].
Topics: Drug Combinations; Guanethidine; Humans; Hydralazine; Hypertension, Renal; Imidazoles; Long-Term Care; Methyldopa; Pargyline; Propylamines; Time Factors | 1973 |
Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat.
Topics: Animals; Brain Chemistry; Chromatography, Ion Exchange; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxydopamines; Male; Methyldopa; Monoamine Oxidase; Pargyline; Phenylacetates; Rats; Time Factors; Tritium; Tyrosine | 1974 |
Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155).
Topics: Antihypertensive Agents; Blood Pressure; Cardiac Output; Cardiovascular System; Chlorthalidone; Dye Dilution Technique; Glomerular Filtration Rate; Guanethidine; Hemodynamics; Humans; Hypertension; Imidazoles; Kidney; Methyldopa; Pargyline; Posture; Sodium Chloride; Time Factors; Vascular Resistance | 1969 |
3-O-methyldopa, a new precursor of dopamine.
Topics: Animals; Brain; Brain Chemistry; Carbon Isotopes; Dealkylation; Dihydroxyphenylalanine; Dopamine; Female; Male; Methyldopa; Norepinephrine; Normetanephrine; Pargyline; Phenylacetates; Rats; Tyramine | 1971 |
Tranquilizing and electrophysiological effects of nicotine.
Topics: Animals; Arousal; Cerebral Cortex; Depression, Chemical; Disulfiram; Drug Synergism; Electric Stimulation; Electrodes, Implanted; Electroencephalography; Evoked Potentials; Exploratory Behavior; Injections, Intravenous; Male; Methyldopa; Methyltyrosines; Mice; Motor Cortex; Nicotine; Pargyline; Photic Stimulation; Rabbits; Sleep | 1972 |
m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Anticonvulsants; Atropine; Azoles; Brain; Chlordiazepoxide; Chlorpromazine; Citrates; Dihydroxyphenylalanine; Disulfiram; Drug Antagonism; Drug Synergism; Kidney; Lysergic Acid Diethylamide; Male; Methyldopa; Mice; Morphine; Nialamide; Norepinephrine; Pargyline; Phenobarbital; Phenytoin; Reserpine; Seizures; Serotonin; Strychnine; Tetrabenazine; Trimethadione; Tyrosine; Urea | 1967 |
Mechanisms of antihypertensive drug therapy.
Topics: Antihypertensive Agents; Blood Pressure; Cardiac Output; Diuretics; Ganglia, Autonomic; Guanethidine; Hemodynamics; Humans; Hydralazine; Hypothalamus; Injections; Kidney; Methyldopa; Nerve Fibers, Myelinated; Neuroeffector Junction; Pargyline; Plants, Medicinal; Rauwolfia; Sympathetic Nervous System; Time Factors; Vascular Resistance; Vasomotor System; Water-Electrolyte Balance | 1970 |
[Secondary effects of hypotensive drugs in arterial hypertension of renal origin].
Topics: Adult; Antihypertensive Agents; Female; Guanethidine; Humans; Hydralazine; Hypertension, Renal; Kidney Diseases; Kidney Failure, Chronic; Male; Methyldopa; Middle Aged; Pargyline | 1970 |
The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors.
Topics: Amphetamine; Animals; Blood Pressure; Cats; Drug Synergism; Epinephrine; Methyldopa; Nialamide; Norepinephrine; Pargyline; Proadifen; Rats; Tranylcypromine; Tyramine | 1968 |
Chronotropic responses to catecholamines as a function of monoamine oxidase activity in the isolated perfused rat heart.
Topics: Animals; Catecholamines; Dopamine; Heart; Male; Methyldopa; Monoamine Oxidase; Pargyline; Rats; Time Factors | 1968 |
An approach to the medical treatment of hypertension in the aged.
Topics: Age Factors; Aged; Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Diuretics; Guanethidine; Headache; Heart Failure; Humans; Hydralazine; Hypertension; Kidney Failure, Chronic; Methyldopa; Pargyline | 1969 |
Hypotensive drug therapy in the management of hypertension.
Topics: Antihypertensive Agents; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Methyldopa; Pargyline; Reserpine; Spironolactone | 1969 |
Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.
Topics: Amphetamine; Animals; Avoidance Learning; Behavior, Animal; Brain Chemistry; Chlorpromazine; Dopamine; Enzymes; Methyldopa; Methyltyrosines; Mixed Function Oxygenases; Nialamide; Norepinephrine; Pargyline; Rats; Serotonin; Tranylcypromine; Tyrosine | 1965 |
Hallucinosis on combined methyldopa and pargyline.
Topics: Drug Synergism; Female; Hallucinations; Humans; Hypertension; Methyldopa; Middle Aged; Pargyline | 1966 |
The role of monoamine oxidase in the intraneuronal metabolism of norepinephrine released by indirectly-acting sympathomimetic amines or by adrenergic nerve stimulation.
Topics: Animals; Cocaine; Dextroamphetamine; Female; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Mephentermine; Methyldopa; Monoamine Oxidase; Neurons; Norepinephrine; Pargyline; Sympathetic Nervous System; Sympathomimetics; Tritium; Tyramine; Urine | 1966 |
Renal pharmacodynamics of antihypertensive drugs: clinical applications.
Topics: Glomerular Filtration Rate; Guanethidine; Humans; Hydralazine; Hypertension; Kidney Diseases; Methyldopa; Pargyline; Phytotherapy; Plants, Medicinal; Rauwolfia | 1966 |
[Treatment of arterial hypertension with guanethidine, 1-alpha-methyldopa and pargyline hydrochloride].
Topics: Guanethidine; Humans; Hypertension; Methyldopa; Pargyline | 1966 |
Evidence for a neurotransmitter role for 5-hydroxytryptamine in chick retina.
Topics: 5-Hydroxytryptophan; Animals; Chickens; Darkness; Dihydroxyphenylalanine; Dopamine; Kinetics; Light; Methyldopa; Neurotransmitter Agents; Pargyline; Retina; Serotonin | 1981 |
[THE MEDICAL TREATMENT OF HYPERTENSION].
Topics: Alkaloids; Antihypertensive Agents; Diuretics; Ganglionic Blockers; Guanethidine; Hydralazine; Hypertension; Hypnotics and Sedatives; Methyldopa; Monoamine Oxidase Inhibitors; Pargyline; Rauwolfia; Veratrum; Veratrum Alkaloids | 1964 |
DRUG THERAPY OF HYPERTENSION.
Topics: Alkaloids; Antihypertensive Agents; Chlorothiazide; Diuretics; Ganglionic Blockers; Guanethidine; Hydralazine; Hypertension; Methyldopa; Monoamine Oxidase Inhibitors; Norepinephrine; Pargyline; Quinidine; Rauwolfia; Veratrum; Veratrum Alkaloids | 1964 |
[NEW HYPOTENSIVE DRUGS].
Topics: Alkaloids; Antihypertensive Agents; Ethacrynic Acid; Humans; Hypotension; Methyldopa; Pargyline; Pharmacology; Rauwolfia | 1964 |
ANTIHYPERTENSIVE AGENTS WHICH IMPAIR ADRENERGIC NEURON TRANSMISSION.
Topics: Adrenergic Neurons; Antihypertensive Agents; Drug Therapy; Guanethidine; Humans; Methyldopa; Neural Conduction; Pargyline; Pharmacology; Toxicology | 1965 |
RECENT ADVANCES AND TRENDS IN DRUG THERAPY. 3. HYPOTENSIVE AGENTS.
Topics: Antihypertensive Agents; Carbamates; Diazoxide; Drug Therapy; Guanethidine; Methyldopa; Pargyline; Toxicology | 1964 |
COMPARATIVE EFFECTIVENESS OF PARGYLINE AS AN ANTIHYPERTENSIVE AGENT.
Topics: Antihypertensive Agents; Biomedical Research; Drug Therapy; Guanethidine; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Methyldopa; Pargyline; Pharmacology; Placebos; Toxicology | 1964 |
CARDIOVASCULAR RENAL AGENTS AS THEY IMPINGE ON OPHTHALMIC PRACTICE.
Topics: Antihypertensive Agents; Benzothiadiazines; Bretylium Compounds; Carbonic Anhydrase Inhibitors; Cardiovascular Agents; Diuretics; Drug Therapy; Glycerol; Guanethidine; Hexamethonium Compounds; Hydralazine; Mannitol; Mecamylamine; Methyldopa; Mineralocorticoid Receptor Antagonists; Ophthalmology; Organomercury Compounds; Pargyline; Pentolinium Tartrate; Renal Agents; Reserpine; Tetraethylammonium Compounds; Toxicology; Urea; Veratrum; Veratrum Alkaloids | 1964 |
HEMODYNAMIC RESPONSE TO ANTIHYPERTENSIVE DRUG THERAPY.
Topics: Antihypertensive Agents; Blood Circulation; Blood Flow Velocity; Blood Pressure; Cardiac Output; Drug Therapy; Guanethidine; Heart Function Tests; Hemodynamics; Humans; Hydralazine; Hypertension; Methyldopa; Pargyline; Rauwolfia; Toxicology; Vascular Resistance | 1965 |
[THE UPTAKE OF ALPHA-METHYLNORADRENALIN INTO THE ISOLATED RABBIT HEART AND ITS LIBERATION BY RESERPINE AND GUANETHIDINE IN VIVO].
Topics: Guanethidine; Heart; Metabolism; Methyldopa; Myocardium; Pargyline; Pharmacology; Rabbits; Research; Reserpine; Sympathetic Nervous System | 1965 |
THE CLINICAL PHARMACOLOGY OF POSTGANGLIONIC SYMPATHETIC BLOCKING AGENTS.
Topics: Antihypertensive Agents; Bretylium Compounds; Ganglionic Blockers; Guanethidine; Metabolism; Methyldopa; Neurophysiology; Norepinephrine; Pargyline; Pharmacology; Rabbits; Rats; Research; Reserpine; Sympathetic Nervous System; Sympatholytics | 1965 |